Variables | HR | 95% CI | P value |
HLA class II on TILs (negative vs positive) | 0.507 | 0.288 to 0.893 | 0.019* |
HLA class II on tumor cells (negative vs positive) | 1.964 | 0.885 to 4.355 | 0.097 |
PD-1 on TILs (negative vs positive)28 | 0.602 | 0.342 to 1.059 | 0.078 |
PD-L1 on TILs (negative vs positive)28 | 0.417 | 0.223 to 0.779 | 0.006* |
PD-L1 on tumor cells (negative vs positive) | 0.815 | 0.198 to 3.347 | 0.776 |
FOXP3 (negative vs positive)28 | 0.376 | 0.194 to 0.730 | 0.004* |
CD3 (negative vs positive)28 | 0.480 | 0.281 to 0.820 | 0.007* |
CD4 (negative vs positive)28 | 0.450 | 0.245 to 0.825 | 0.010* |
CD8 (negative vs positive)28 | 0.400 | 0.206 to 0.776 | 0.007* |
*P<0.05 indicates statistical significance.
HLA class II, human leukocyte antigen class II; PD-1, programmed death-1; PD-L1, programmed death-ligand 1; TILs, tumor infiltrating lymphocytes.